Taysha Gene Therapies
TSHA
₹228.15
Share price
-1.87%
Change (1 day)
18.98%
Change (1 year)
Taysha Gene Therapies (TSHA) - Total assets
Total assets on the balance sheet as of March 2025 : ₹12.04 Billion
According to Taysha Gene Therapies's latest financial reports the company's total assets are ₹12.04 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Taysha Gene Therapies - Total assets on balance sheet (from 2020 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | ₹13.75 B | -4.33% |
| 2023-12-31 | ₹14.37 B | 37.61% |
| 2022-12-31 | ₹10.44 B | -34.38% |
| 2021-12-31 | ₹15.92 B | -15.89% |
| 2020-12-31 | ₹18.93 B | 1769893.83% |
| 2019-12-31 | ₹1.06 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | ₹21.14 B | 75.52% | 🇺🇸 USA |